Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Velneperit

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet

Shionogi · Phase 2 · Completed · Enrollment 842

NCT00748605

ArmPopulationDoseWeeksEstimandWeight change
PlaceboObesity or overweightn/r54n/rn/r
S-2367 1600 mg q.d. 54 weeksObesity or overweight1600 mg54n/rn/r
S-2367 1600 mg q.d. 60 weeksObesity or overweight1600 mg54n/rn/r